⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL159223 | 1.00 | — | — | |
| SCHEMBL186262 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL1337777 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL159221 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL7073280 | 0.97 | SMN1; SMN2 (0.39) | — | |
| SCHEMBL2236696 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL5276199 | 0.97 | SMN1; SMN2 (0.39) | — | |
| Hydrochloric Acid SCHEMBL159222 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL74754 | 0.97 | — | — | |
| Hypochlorous Acid SCHEMBL21244360 | 0.95 | SMN1; SMN2 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 757 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116332780-B | Synthesis method of S-3-chloro-D-alanine methyl ester hydrochloride | 河北国龙制药有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-118271200-A | Industrial preparation method and application of lacosamide | 北京澳合药物研究院有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-116332780-A | Synthesis method of S-3-chloro-D-alanine methyl ester hydrochloride | 河北国龙制药有限公司 | 2023-06-27 | — | — | CN | claimed |
| CN-105949074-B | A kind of synthetic method of O methyl D serines | 南京红杉生物科技有限公司 | 2018-03-02 | — | — | CN | claimed |
| CN-105949074-A | Synthesis method of O-methyl-D-serine | 南京红杉生物科技有限公司 | 2016-09-21 | — | — | CN | claimed |
| CN-103319366-A | Lacosamide synthesis technology | WUHAN INST TECHNOLOGY | 2013-09-25 | — | — | CN | claimed |
| CN-1329403-C | A method for preparing N-acyl lysophosphatidylcholine compound and a pharmaceutical composition containing the compound for treating metabolic bone disease | JHON GIL JA (KR) | 2007-08-01 | — | — | CN | claimed |
| CN-1608073-A | A method for preparing N-acyl lysophosphatidylcholine compound and a pharmaceutical composition containing the compound for treating metabolic bone disease | JHON GIL JA (KR) | 2005-04-20 | — | — | CN | claimed |
| US-12528785-B2 | MDM2 degraders and uses thereof | KYMERA THERAPEUTICS, INC. (US) | 2026-01-20 | — | — | US | disclosed |
| US-12473252-B2 | Processes for the preparation of deuterated D-serine | SUN PHARMACEUTICAL INDUSTRIES, INC. (US) | 2025-11-18 | — | — | US | disclosed |
| CN-120971604-A | Detection method of related substances in cycloserine | 河北广祥制药有限公司 | 2025-11-18 | — | — | CN | disclosed |
| US-20250339388-A1 | PHENYLALANINE-BASED LAT1 INHIBITORS AND USES THEREOF | MAXYMUNE THERAPEUTICS INC (US) | 2025-11-06 | — | — | US | disclosed |
| US-20250319046-A1 | PHENYLALANINE-BASED LAT1 INHIBITORS AND USES THEREOF | MAXYMUNE THERAPEUTICS INC (US) | 2025-10-16 | — | — | US | disclosed |
| EP-3483142-B1 | AROMATIC ACETYLENE OR AROMATIC ETHYLENE COMPOUND, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF | BEIJING MAXINOVEL PHARMACEUTICALS CO LTD (CN) | 2025-10-15 | — | — | EP | disclosed |
| US-4663320-A | ANTITUMOR AGENTS, ANTICOAGULANTS | SYNTEX (U.S.A.) INC. (US) | 1987-05-05 | — | — | US | disclosed |
| US-4640913-A | Phosphocholine derivatives having antihypertensive action | AMERICAN CYANAMID COMPANY (US) | 1987-02-03 | — | — | US | disclosed |
| US-4551459-A | Method of treating heart failure using (2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-b]quinazolinyl)oxyalkylamides | SYNTEX (U.S.A.) INC. (US) | 1985-11-05 | — | — | US | disclosed |
| EP-0153152-A2 | (2-Oxo-1,2,3,5-tetrahydroimidazo-/2,1-b/quinnazolinyl)-oxyalkylamides, their preparation, compositions containing them and their use in making medicaments | SYNTEX (U.S.A.) INC. (US) | 1985-08-28 | — | — | EP | disclosed |
| EP-0144840-A2 | Optically active beta-lactams and method of their production | Takeda Chemical Industries, Ltd. (JP) | 1985-06-19 | — | — | EP | disclosed |
| EP-0116948-A2 | (2-Oxo-1,2,3,5-tetrahydroimidazo-(2,1-b)quinazolinyl)-oxyalkyl-amides | SYNTEX (U.S.A.) INC. (US) | 1984-08-29 | — | — | EP | disclosed |